BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bian Q, Chen J, Qiu W, Peng C, Song M, Sun X, Liu Y, Ding F, Chen J, Zhang L. Four targeted genes for predicting the prognosis of colorectal cancer: A bioinformatics analysis case. Oncol Lett 2019;18:5043-54. [PMID: 31612015 DOI: 10.3892/ol.2019.10866] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Mohammed M, Mboya IB, Mwambi H, Elbashir MK, Omolo B. Predictors of colorectal cancer survival using cox regression and random survival forests models based on gene expression data. PLoS One 2021;16:e0261625. [PMID: 34965262 DOI: 10.1371/journal.pone.0261625] [Reference Citation Analysis]
2 Du W, Miao Y, Zhang G, Luo G, Yang P, Chen F, Zhang B, Yang C, Li G, Chang J, Xu Y. The Regulatory Role of Neuropeptide Gene Glucagon in Colorectal Cancer: A Comprehensive Bioinformatic Analysis. Disease Markers 2022;2022:1-17. [DOI: 10.1155/2022/4262600] [Reference Citation Analysis]
3 Wang Y, Lin K, Xu T, Wang L, Fu L, Zhang G, Ai J, Jiao Y, Zhu R, Han X, Cai H. Development and validation of prognostic model based on the analysis of autophagy-related genes in colon cancer. Aging (Albany NY) 2021;13:19028-47. [PMID: 34315829 DOI: 10.18632/aging.203352] [Reference Citation Analysis]
4 Wu N, Feng YQ, Lyu N, Wang D, Yu WD, Hu YF. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model. World J Gastroenterol 2022; 28(18): 1981-1995 [DOI: 10.3748/wjg.v28.i18.1981] [Reference Citation Analysis]
5 Zhou J, Xie Z, Cui P, Su Q, Zhang Y, Luo L, Li Z, Ye L, Liang H, Huang J. SLC1A1, SLC16A9, and CNTN3 Are Potential Biomarkers for the Occurrence of Colorectal Cancer. Biomed Res Int 2020;2020:1204605. [PMID: 32566650 DOI: 10.1155/2020/1204605] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Susmi TF, Rahman A, Khan MMR, Yasmin F, Islam MS, Nasif O, Alharbi SA, Batiha GE, Hossain MU. Prognostic and clinicopathological insights of phosphodiesterase 9A gene as novel biomarker in human colorectal cancer. BMC Cancer 2021;21:577. [PMID: 34016083 DOI: 10.1186/s12885-021-08332-3] [Reference Citation Analysis]
7 Kasprzak A, Adamek A. The Neuropeptide System and Colorectal Cancer Liver Metastases: Mechanisms and Management. Int J Mol Sci 2020;21:E3494. [PMID: 32429087 DOI: 10.3390/ijms21103494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Sun Z, Liu C, Cheng SY. Identification of four novel prognosis biomarkers and potential therapeutic drugs for human colorectal cancer by bioinformatics analysis. J Biomed Res 2020;35:21-35. [PMID: 33361643 DOI: 10.7555/JBR.34.20200021] [Reference Citation Analysis]
9 Bourdakou MM, Spyrou GM, Kolios G. Colon Cancer Progression Is Reflected to Monotonic Differentiation in Gene Expression and Pathway Deregulation Facilitating Stage-specific Drug Repurposing. Cancer Genomics Proteomics 2021;18:757-69. [PMID: 34697067 DOI: 10.21873/cgp.20295] [Reference Citation Analysis]
10 Yin H, Chu A, Liu S, Yuan Y, Gong Y. Identification of DEGs and transcription factors involved in H. pylori-associated inflammation and their relevance with gastric cancer. PeerJ 2020;8:e9223. [PMID: 32547867 DOI: 10.7717/peerj.9223] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]